Monday - February 23, 2026
FDA Center for Veterinary Medicine Issues Warning Letter to Elanco Animal Health USA
February 19, 2026
WASHINGTON, Feb. 19 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Elanco Animal Health USA from the Center for Veterinary Medicine:

* * *

Recipient: Jeffrey Simmons, President and CEO, Elanco Animal Health USA, 2500 Innovation Way, Greenfield, IN 46140, United States

Issuing Office: Center for Veterinary Medicine, United States

Re: NADA 141-550 Pradalex(TM) (pradofloxacin . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products